Researchers at St. Michael's Hospital and the University of Toronto have found that American ginseng reduces the levels before meal blood sugar in patients with and without diabetes. The study appears in Archives of Internal Medicine, a publication of the Journal of American Medical Association (JAMA).
Participants in the study, both diabetes (type 2) diabetic and non-consumed capsules containing three grams of soil in Ontario grown American ginseng 40 minutes before or during a glucose test. Among participants with type 2 diabetes who received capsules of ginseng experienced a 20 percent reduction in blood glucose levels compared with placebo, when taking capsules.
Although the results are encouraging, Vuksan, Associate Director of the Center for modification of risk factors in the St. Michael's Hospital and professor in the Department of Nutritional Sciences, University of Toronto, cautions that these results, people do not be used as an excuse to start taking ginseng. This is a first short-term study shows that only a need for further research.
Besides the impact on the management of diabetes, this study is of great importance for research on herbs as any medical treatment, an area that has caused great public controversy in recent years. This study represents an important step in the evaluation of the plant, says Vuksan. Most critical is the investigation of ginseng plants and lack of recent scientific, placebo-controlled trials in humans. Our study used traditional clinical standards, research on alternative medicine.